ConceptMedicine
INDIGO trial
A phase 3 double-blinded, randomized placebo-controlled trial evaluating vorasidenib versus placebo in patients with residual or recurrent grade 2 gliomas not treated beyond surgery.
Know first
Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.
Clinical trial design1Low-grade gliomas1
Lecturers
1Connections
1The lectures that define it or assume it, and the concepts next to it.